Company: OCEA
Filing Date: 2025-04-01
Form Type: NT 10-K
Source: 0001641172-25-002034
Chunk: 1

Company: Ocean Biomedical, Inc.
Filing Date: 2025-04-01
Form: NT 10-K
Chunk 1
---
 accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.                               |

PART III - NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 11-K, 20-F, 10-Q, N-SAR, or the transition report portion thereof, could not be filed within the prescribed time period.

There will be a delay in filing the Annual Report on Form 10-K of Ocean Biomedical, Inc. (the “Company”) for the period ended December 31, 2024 (the “Annual Report”). The Company has determined that it is unable to file its Annual Report within the prescribed time period without unreasonable effort or expense because of the late receipt of certain required information from third parties in order for the auditor to complete its procedures. The Company anticipates filing its 10-K by the end of this week and certainly within the delay period provided under SEC rules.

PART IV - OTHER INFORMATION

| (1) | Name                                                                      
 and telephone number of person to contact in regard to this notification: |

| Jolie  
 Kahn   |     | (401)                   
 444-7375                |
| (Name) |     | -Area                   
 Code) (Telephone number |

| (2) | Have                                                                                                                                   
 all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment   
 Company Act of 1940 during the preceding 12 months (or for such shorter) period that the registrant was required to file such reports) 
 been filed? If answer is no, identify report(s): ☒Yes ☐ No                                                                             |
| (3) | Is                                                                                                                                     
 it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be     
 reflected by the earnings statements to be included in the subject report or portion thereof: ☐Yes ☒ No                                |

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

<div align='center'>Ocean Biomedical, Inc.

(Name of Registrant as Specified in Charter)</div>

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

| Date: | April   
 1, 2025 |     | By: | /s/               
 Jolie Kahn        |
|:------|